: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Obstructive Lung Diseases

Free Subscription

Articles published in Respir Res
Retrieve available abstracts of 372 articles:
HTML format

Single Articles

April 2024

DING Y, Wang Z, Zhang Z, You R, et al
GLUT3-mediated cigarette smoke-induced epithelial-mesenchymal transition in chronic obstructive pulmonary disease through the NF-kB/ZEB1 pathway.
Respir Res. 2024;25:158.
PubMed Abstract available

March 2024

BERGWIK J, Liu J, Padra M, Bhongir RKV, et al
A novel quinoline with airway relaxant effects and anti-inflammatory properties.
Respir Res. 2024;25:146.
PubMed Abstract available

KIM T, Shin SH, Kim H, Im Y, et al
Longitudinal BMI change and outcomes in Chronic Obstructive Pulmonary Disease: a nationwide population-based cohort study.
Respir Res. 2024;25:150.
PubMed Abstract available

DING H, Yan L, Wang Y, Lu Y, et al
Astaxanthin attenuates cigarette smoke-induced small airway remodeling via the AKT1 signaling pathway.
Respir Res. 2024;25:148.
PubMed Abstract available

LU L, Wu F, Peng J, Wu X, et al
Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
Respir Res. 2024;25:149.
PubMed Abstract available

WU J, Meng W, Ma Y, Zhao Z, et al
Early smoking lead to worse prognosis of COPD patients: a real world study.
Respir Res. 2024;25:140.
PubMed Abstract available

HSU YT, Wu CC, Wang CC, Sheu CC, et al
Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters.
Respir Res. 2024;25:139.
PubMed Abstract available

MEI S, Li D, Wang A, Zhu G, et al
The role of sialidase Neu1 in respiratory diseases.
Respir Res. 2024;25:134.
PubMed Abstract available

SHIN SH, Kim T, Kim H, Cho J, et al
Impact of smoking reduction on lung cancer risk in patients with COPD who smoked fewer than 30 pack-years: a nationwide population-based cohort study.
Respir Res. 2024;25:133.
PubMed Abstract available

MCCLUSKEY ES, Liu N, Pandey A, Marchetti N, et al
Quercetin improves epithelial regeneration from airway basal cells of COPD patients.
Respir Res. 2024;25:120.
PubMed Abstract available

HONG X, Jiang M, Kho AT, Tiwari A, et al
Circulating miRNAs associate with historical childhood asthma hospitalization in different serum vitamin D groups.
Respir Res. 2024;25:118.
PubMed Abstract available

CAI R, Gong X, Li X, Jiang Y, et al
Dectin-1 aggravates neutrophil inflammation through caspase-11/4-mediated macrophage pyroptosis in asthma.
Respir Res. 2024;25:119.
PubMed Abstract available

LAN G, Xie M, Lan J, Huang Z, et al
Association and mediation between educational attainment and respiratory diseases: a Mendelian randomization study.
Respir Res. 2024;25:115.
PubMed Abstract available

WU Y, He B, Hua J, Hu W, et al
Deciphering the molecular regulatory of RAB32/GPRC5A axis in chronic obstructive pulmonary disease.
Respir Res. 2024;25:116.
PubMed Abstract available

February 2024

MATERA MG, Rinaldi B, Calabrese C, Belardo C, et al
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro.
Respir Res. 2024;25:104.
PubMed Abstract available

BELL AJ, Pal R, Labaki WW, Hoff BA, et al
Local heterogeneity of normal lung parenchyma and small airways disease are associated with COPD severity and progression.
Respir Res. 2024;25:106.
PubMed Abstract available

SIROUX V, Boudier A, Lyon-Caen S, Quentin J, et al
Intra-breath changes in respiratory mechanics are sensitive to history of respiratory illness in preschool children: the SEPAGES cohort.
Respir Res. 2024;25:99.
PubMed Abstract available

CHANG C, Huang K, Xu X, Duan R, et al
MiR-23a-5p alleviates chronic obstructive pulmonary disease through targeted regulation of RAGE-ROS pathway.
Respir Res. 2024;25:93.
PubMed Abstract available

TU J, Wen J, Luo Q, Li X, et al
Causal relationships of metabolites with allergic diseases: a trans-ethnic Mendelian randomization study.
Respir Res. 2024;25:94.
PubMed Abstract available

SUN J, Deng YP, Xu J, Zhu FM, et al
Association of blood cadmium concentration with chronic obstructive pulmonary disease progression: a prospective cohort study.
Respir Res. 2024;25:91.
PubMed Abstract available

ZHANG J, Yi Q, Zhou C, Luo Y, et al
A simple clinical risk score (ABCDMP) for predicting mortality in patients with AECOPD and cardiovascular diseases.
Respir Res. 2024;25:89.
PubMed Abstract available

GAO J, Um-Bergstrom P, Pourbazargan M, Berggren-Brostrom E, et al
Large airway T cells in adults with former bronchopulmonary dysplasia.
Respir Res. 2024;25:86.
PubMed Abstract available

LU T, Lahousse L, Wijnant S, Chen J, et al
The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.
Respir Res. 2024;25:85.
PubMed Abstract available

LIU S, Tan X, Liu S
The role of extracellular vesicles in COPD and potential clinical value.
Respir Res. 2024;25:84.
PubMed Abstract available

WU W, Li J, Chen S, Ouyang S, et al
The airway neuro-immune axis as a therapeutic target in allergic airway diseases.
Respir Res. 2024;25:83.
PubMed Abstract available

GAYEN SK, Zulty M, Criner GJ
Elevated pulmonary vascular resistance is associated with increased lung transplant waitlist mortality among patients with chronic obstructive pulmonary disease and pulmonary hypertension: a retrospective cohort analysis.
Respir Res. 2024;25:79.
PubMed Abstract available

YU X, Li L, Cai B, Zhang W, et al
Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma.
Respir Res. 2024;25:76.
PubMed Abstract available

ZHANG Q, Yan L, Lu Y, Liu X, et al
HDAC6-selective inhibitor CAY10603 ameliorates cigarette smoke-induced small airway remodeling by regulating epithelial barrier dysfunction and reversing.
Respir Res. 2024;25:66.
PubMed Abstract available

LU F, Yao LP, Gao DD, Alinejad T, et al
MicroRNA-377-3p exacerbates chronic obstructive pulmonary disease through suppressing ZFP36L1 expression and inducing lung fibroblast senescence.
Respir Res. 2024;25:67.
PubMed Abstract available

CHANG YP, Tsai YH, Chen YM, Huang KT, et al
Upregulated microRNA-125b-5p in patients with asthma-COPD overlap mediates oxidative stress and late apoptosis via targeting IL6R/TRIAP1 signaling.
Respir Res. 2024;25:64.
PubMed Abstract available

January 2024

FAHNDRICH S, Herr C, Teuteberg S, Alter P, et al
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET.
Respir Res. 2024;25:56.
PubMed Abstract available

AUDOUSSET C, Swaleh S, Olivenstein R, Vameghestahbanati M, et al
Mucus plugs in the airways of asthmatic subjects and smoking status.
Respir Res. 2024;25:52.
PubMed Abstract available

UPADHYAY S, Rahman M, Rinaldi S, Koelmel J, et al
Assessment of wood smoke induced pulmonary toxicity in normal- and chronic bronchitis-like bronchial and alveolar lung mucosa models at air-liquid interface.
Respir Res. 2024;25:49.
PubMed Abstract available

CHENG ZJ, Wu H, Chang Z, Cheng J, et al
The genetic etiology of body fluids on chronic obstructive airways disease.
Respir Res. 2024;25:46.
PubMed Abstract available

WELLS AU, Jacob J, Sverzellati N, Cross G, et al
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema.
Respir Res. 2024;25:33.
PubMed Abstract available

ZOLLER D, Haverkamp C, Makoudjou A, Sofack G, et al
Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning.
Respir Res. 2024;25:38.
PubMed Abstract available

KWOK WC, Tam TCC, Ho JCM, Lam DCL, et al
Hospitalized acute exacerbation in chronic obstructive pulmonary disease - impact on long-term renal outcomes.
Respir Res. 2024;25:36.
PubMed Abstract available

WHITTAKER HR, Torkpour A, Quint J
Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data.
Respir Res. 2024;25:43.
PubMed Abstract available

WARE SA, Kliment CR, Giordano L, Redding KM, et al
Cell-free DNA levels associate with COPD exacerbations and mortality.
Respir Res. 2024;25:42.
PubMed Abstract available

REUTER S, Raspe J, Taube C
Microbes little helpers and suppliers for therapeutic asthma approaches.
Respir Res. 2024;25:29.
PubMed Abstract available

LI Z, Cheng T, Guo Y, Gao R, et al
CD147 induces asthmatic airway remodeling and activation of circulating fibrocytes in a mouse model of asthma.
Respir Res. 2024;25:6.
PubMed Abstract available

COOK S, Buskiewicz J, Levy DT, Meza R, et al
Association between cigar use, with and without cigarettes, and incident diagnosed COPD: a longitudinal cohort study.
Respir Res. 2024;25:13.
PubMed Abstract available

DETSIKA MG, Palamaris K, Dimopoulou I, Kotanidou A, et al
The complement cascade in lung injury and disease.
Respir Res. 2024;25:20.
PubMed Abstract available

DEDONDER J, Gelgon C, Guerder A, Nion N, et al
"In their own words": delineating the contours of dyspnea invisibility in patients with advanced chronic obstructive pulmonary disease from quantitative discourse analysis.
Respir Res. 2024;25:21.
PubMed Abstract available

PENG W, Xia Q, Zhang Y, Cao D, et al
VEGF and EGFR signaling pathways are involved in the baicalein attenuation of OVA-induced airway inflammation and airway remodeling in mice.
Respir Res. 2024;25:10.
PubMed Abstract available

FANG ZF, Wang ZN, Chen Z, Peng Y, et al
Fine particulate matter contributes to COPD-like pathophysiology: experimental evidence from rats exposed to diesel exhaust particles.
Respir Res. 2024;25:14.
PubMed Abstract available

December 2023

LI C, Liu Q, Chang Q, Xie M, et al
Role of mitochondrial fusion proteins MFN2 and OPA1 on lung cellular senescence in chronic obstructive pulmonary disease.
Respir Res. 2023;24:319.
PubMed Abstract available

LOPEZ K, Li H, Lipkin-Moore Z, Kay S, et al
Deep learning prediction of hospital readmissions for asthma and COPD.
Respir Res. 2023;24:311.
PubMed Abstract available

EL-HUSSEINI ZW, Khalenkow D, Lan A, van der Molen T, et al
An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.
Respir Res. 2023;24:308.
PubMed Abstract available

AKENROYE A, Nopsopon T, Cho L, Moll M, et al
Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses.
Respir Res. 2023;24:305.
PubMed Abstract available

HORVAT JC, Kim RY, Weaver N, Augood C, et al
Characterization and inhibition of inflammasome responses in severe and non-severe asthma.
Respir Res. 2023;24:303.
PubMed Abstract available

HWANG H, Jang JH, Lee E, Park HS, et al
Prediction of the number of asthma patients using environmental factors based on deep learning algorithms.
Respir Res. 2023;24:302.
PubMed Abstract available

LI C, Chen F, Lin L, Li J, et al
CSE triggers ferroptosis via SIRT4-mediated GNPAT deacetylation in the pathogenesis of COPD.
Respir Res. 2023;24:301.
PubMed Abstract available

November 2023

CHEN B, Liu Z, Lu J, Li Z, et al
Deep learning parametric response mapping from inspiratory chest CT scans: a new approach for small airway disease screening.
Respir Res. 2023;24:299.
PubMed Abstract available

ZHU W, Han L, Wu Y, Tong L, et al
Keratin 15 protects against cigarette smoke-induced epithelial mesenchymal transformation by MMP-9.
Respir Res. 2023;24:297.
PubMed Abstract available

KANSAL H, Chopra V, Garg K, Sharma S, et al
Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target.
Respir Res. 2023;24:295.
PubMed Abstract available

GAGNON PA, Klein M, De Vos J, Biardel S, et al
S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty.
Respir Res. 2023;24:294.
PubMed Abstract available

SWART KMA, Baak BN, Lemmens L, Penning-van Beest FJA, et al
Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.
Respir Res. 2023;24:293.
PubMed Abstract available

CRAPO JD, Gupta A, Lynch DA, Turner AM, et al
Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study.
Respir Res. 2023;24:290.
PubMed Abstract available

VAN DER SAR IG, Wijsenbeek MS, Braunstahl GJ, Loekabino JO, et al
Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
Respir Res. 2023;24:271.
PubMed Abstract available

TEE JH, Vijayakumar U, Shanmugasundaram M, Lam TYW, et al
Isthmin-1 attenuates allergic Asthma by stimulating adiponectin expression and alveolar macrophage efferocytosis in mice.
Respir Res. 2023;24:269.
PubMed Abstract available

CHOI B, San Jose Estepar R, Godbole S, Curtis JL, et al
Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers.
Respir Res. 2023;24:265.
PubMed Abstract available

YI XZ, Yang JH, Huang Y, Han XR, et al
Differential airway resistome and its correlations with clinical characteristics in Haemophilus- or Pseudomonas-predominant microbial subtypes of bronchiectasis.
Respir Res. 2023;24:264.
PubMed Abstract available

October 2023

HEMPEL P, Klein V, Michely A, Boll S, et al
Amitriptyline inhibits bronchoconstriction and directly promotes dilatation of the airways.
Respir Res. 2023;24:262.
PubMed Abstract available

CHANG C, Chen G, Wu W, Chen D, et al
Exogenous IL-25 ameliorates airway neutrophilia via suppressing macrophage M1 polarization and the expression of IL-12 and IL-23 in asthma.
Respir Res. 2023;24:260.
PubMed Abstract available

WERDECKER C, Bals R
Impact of the COVID-19 pandemic on well-being and quality of life of patients with alpha-1-antitrypsin deficiency.
Respir Res. 2023;24:258.
PubMed Abstract available

LIU L, Zhou L, Wang L, Mao Z, et al
MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-kappaB pathway.
Respir Res. 2023;24:255.
PubMed Abstract available

YASUDA Y, Wang L, Chitano P, Seow CY, et al
Critical roles of airway smooth muscle in mediating deep-inspiration-induced bronchodilation: a big stretch?
Respir Res. 2023;24:250.
PubMed Abstract available

SKLOOT GS, Guasconi A, Lavon BR, Georges G, et al
The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN).
Respir Res. 2023;24:244.
PubMed Abstract available

BRETTONI C, Muzzi A, Rondini S, Weynants V, et al
Ex-vivo RNA expression analysis of vaccine candidate genes in COPD sputum samples.
Respir Res. 2023;24:243.
PubMed Abstract available

September 2023

CHEN CY, Pan SW, Hsu CC, Liu JJ, et al
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework.
Respir Res. 2023;24:239.
PubMed Abstract available

SPECTOR C, De Sanctis CM, Panettieri RA Jr, Koziol-White CJ, et al
Rhinovirus induces airway remodeling: what are the physiological consequences?
Respir Res. 2023;24:238.
PubMed Abstract available

PADILLA-GALO A, Moya Carmona I, Ausin P, Carazo Fernandez L, et al
Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.
Respir Res. 2023;24:235.
PubMed Abstract available

RONN C, Kamstrup P, Eklof J, Toennesen LL, et al
Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients.
Respir Res. 2023;24:232.
PubMed Abstract available

SHEN K, Zhang M, Zhao R, Li Y, et al
Eosinophil extracellular traps in asthma: implications for pathogenesis and therapy.
Respir Res. 2023;24:231.
PubMed Abstract available

USMANI O, Li G, De Backer J, Sadafi H, et al
Modeled small airways lung deposition of two fixed-dose triple therapy combinations assessed with in silico functional respiratory imaging.
Respir Res. 2023;24:226.
PubMed Abstract available

KARAKIOULAKI M, Berkemeier CM, Heijnen I, Grize L, et al
Staphylococcus aureus enterotoxin A- and B-specific IgE in chronic obstructive pulmonary disease.
Respir Res. 2023;24:225.
PubMed Abstract available

ZOU RH, Nouraie SM, Karoleski C, Zhang Y, et al
Incident low muscle mass is associated with greater lung disease and lower circulating leptin in a tobacco-exposed longitudinal cohort.
Respir Res. 2023;24:224.
PubMed Abstract available

DEY S, Lu W, Haug G, Chia C, et al
Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study.
Respir Res. 2023;24:221.
PubMed Abstract available

LIU J, Chen Y, Chen H, Wang Y, et al
Macrophage migration inhibitory factor exacerbates asthmatic airway remodeling via dynamin-related protein 1-mediated autophagy activation.
Respir Res. 2023;24:216.
PubMed Abstract available

August 2023

YAO X, Chen Q, Wang X, Liu X, et al
IL-25 induces airway remodeling in asthma by orchestrating the phenotypic changes of epithelial cell and fibrocyte.
Respir Res. 2023;24:212.
PubMed Abstract available

TAKEUCHI H, Hasan SMT, Zaman K, Takanashi S, et al
Correction to: Impact of Haemophilus influenzae type b combination vaccination on asthma symptoms and pneumonia in 5-year-old children in rural Bangladesh: a longitudinal study and comparison with a previous cross-sectional study.
Respir Res. 2023;24:210.
PubMed

ELSHOF J, Vonk JM, van der Pouw A, van Dijk C, et al
Clinical practice of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
Respir Res. 2023;24:208.
PubMed Abstract available

WANG Y, Ninaber DK, Faiz A, van der Linden AC, et al
Acute cigarette smoke exposure leads to higher viral infection in human bronchial epithelial cultures by altering interferon, glycolysis and GDF15-related pathways.
Respir Res. 2023;24:207.
PubMed Abstract available

DY ABC, Girkin J, Marrocco A, Collison A, et al
Rhinovirus infection induces secretion of endothelin-1 from airway epithelial cells in both in vitro and in vivo models.
Respir Res. 2023;24:205.
PubMed Abstract available

BURBANK AJ, Atkinson CE, Espaillat AE, Schworer SA, et al
Race-specific spirometry equations may overestimate asthma control in Black children and adolescents.
Respir Res. 2023;24:203.
PubMed Abstract available

TAKIMOTO-SATO M, Suzuki M, Kimura H, Ge H, et al
Apoptosis inhibitor of macrophage (AIM)/CD5L is involved in the pathogenesis of COPD.
Respir Res. 2023;24:201.
PubMed Abstract available

KRAMER EL, Hudock KM, Davidson CR, Clancy JP, et al
CFTR dysfunction in smooth muscle drives TGFbeta dependent airway hyperreactivity.
Respir Res. 2023;24:198.
PubMed Abstract available

July 2023

CAZZOLA M, Page CP, Wedzicha JA, Celli BR, et al
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD.
Respir Res. 2023;24:194.
PubMed Abstract available

COURSE CW, Lewis PA, Kotecha SJ, Cousins M, et al
Characterizing the urinary proteome of prematurity-associated lung disease in school-aged children.
Respir Res. 2023;24:191.
PubMed Abstract available

BALDOMERO AK, MacDonald DM, Kaplan A, Lock E, et al
Bilirubin-associated single nucleotide polymorphism (SNP) and respiratory health outcomes: a mendelian randomization study.
Respir Res. 2023;24:190.
PubMed Abstract available

JONES AC, Leffler J, Laing IA, Bizzintino J, et al
LPS binding protein and activation signatures are upregulated during asthma exacerbations in children.
Respir Res. 2023;24:184.
PubMed Abstract available

STRULOVICI-BAREL Y, Kaner RJ, Crystal RG
High apoptotic endothelial microparticle levels measured in asthma with elevated IgE and eosinophils.
Respir Res. 2023;24:180.
PubMed Abstract available

RASPE J, Schmitz MS, Barbet K, Caso GC, et al
Therapeutic properties of Helicobacter pylori-derived vacuolating cytotoxin A in an animal model of chronic allergic airway disease.
Respir Res. 2023;24:178.
PubMed Abstract available

June 2023

KAMSTRUP P, Sivapalan P, Ronn C, Rastoder E, et al
Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study.
Respir Res. 2023;24:172.
PubMed Abstract available

HAKANSSON KEJ, Guerrero SC, Backer V, Ulrik CS, et al
Burden and unmet need for specialist care in poorly controlled and severe childhood asthma in a Danish nationwide cohort.
Respir Res. 2023;24:173.
PubMed Abstract available

WANG Z, Li Y, Gao Y, Fu Y, et al
Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
Respir Res. 2023;24:169.
PubMed Abstract available

WANG Z, He Y, Li Q, Zhao Y, et al
Dysregulation of iron homeostasis in airways associated with persistent preschool wheezing.
Respir Res. 2023;24:170.
PubMed Abstract available

AHN SY, Lee J, Lee DH, Ho TL, et al
Chronic allergic asthma induces T-cell exhaustion and impairs virus clearance in mice.
Respir Res. 2023;24:160.
PubMed Abstract available

LIU P, Zhang M, Gao H, Han S, et al
Regulation of whole-transcriptome sequencing expression in COPD after personalized precise exercise training: a pilot study.
Respir Res. 2023;24:156.
PubMed Abstract available

DONOGHUE LJ, McFadden KM, Vargas D, Smith GJ, et al
Collaborative cross strain CC011/UncJ as a novel mouse model of T2-high, severe asthma.
Respir Res. 2023;24:153.
PubMed Abstract available

ROGNONI C, Milano C, Heffler E, Bonini M, et al
Economic impact of a more extensive use of FENO testing on the Italian population with asthma.
Respir Res. 2023;24:147.
PubMed Abstract available

TALKER L, Neville D, Wiffen L, Selim AB, et al
Machine diagnosis of chronic obstructive pulmonary disease using a novel fast-response capnometer.
Respir Res. 2023;24:150.
PubMed Abstract available

May 2023

KANJ AN, Kottom TJ, Schaefbauer KJ, Choudhury M, et al
Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans.
Respir Res. 2023;24:144.
PubMed Abstract available

BATTAGLINI D, Parodi L, Cinotti R, Asehnoune K, et al
Ventilator-associated pneumonia in neurocritically ill patients: insights from the ENIO international prospective observational study.
Respir Res. 2023;24:146.
PubMed Abstract available

KNOX-BROWN B, Patel J, Potts J, Ahmed R, et al
The association of spirometric small airways obstruction with respiratory symptoms, cardiometabolic diseases, and quality of life: results from the Burden of Obstructive Lung Disease (BOLD) study.
Respir Res. 2023;24:137.
PubMed Abstract available

VULTAGGIO A, Aliani M, Altieri E, Bracciale P, et al
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
Respir Res. 2023;24:135.
PubMed Abstract available

CIPOLLA D, Zhang J, Korkmaz B, Chalmers JD, et al
Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Respir Res. 2023;24:133.
PubMed Abstract available

WANG R, Huang C, Yang W, Wang C, et al
Respiratory microbiota and radiomics features in the stable COPD patients.
Respir Res. 2023;24:131.
PubMed Abstract available

JUDE MS, Yang CX, Filho FSL, Hernandez Cordero AI, et al
Microbial dysbiosis and the host airway epithelial response: insights into HIV-associated COPD using multi'omics profiling.
Respir Res. 2023;24:124.
PubMed Abstract available

GENOFRE E, Carstens D, DeBacker W, Muchmore P, et al
The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach.
Respir Res. 2023;24:121.
PubMed Abstract available

CHEN W, Reddel HK, FitzGerald JM, Beasley R, et al
Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials.
Respir Res. 2023;24:120.
PubMed Abstract available

April 2023

TOMASZEWSKI EL, Atkinson MJ, Janson C, Karlsson N, et al
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
Respir Res. 2023;24:106.
PubMed Abstract available

GUECAMBURU M, Coquelin A, Rapin A, Le Guen N, et al
Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study.
Respir Res. 2023;24:102.
PubMed Abstract available

LI J, Zheng Z, Liu Y, Zhang H, et al
IRAK-M has effects in regulation of lung epithelial inflammation.
Respir Res. 2023;24:103.
PubMed Abstract available

March 2023

LIN L, Song Q, Duan J, Liu C, et al
The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease.
Respir Res. 2023;24:98.
PubMed Abstract available

LUYSTER FS, Boudreaux-Kelly MY, Bon JM
Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs.
Respir Res. 2023;24:93.
PubMed Abstract available

YANG Z, Li P, Yuan Q, Wang X, et al
Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1.
Respir Res. 2023;24:92.
PubMed Abstract available

ZILLI VIEIRA CL, Koutrakis P, Liu M, Gottlieb DJ, et al
Intense solar activity reduces urinary 6-sulfatoxymelatonin in patients with COPD.
Respir Res. 2023;24:91.
PubMed Abstract available

HE LX, Yang L, Liu T, Li YN, et al
Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation.
Respir Res. 2023;24:90.
PubMed Abstract available

WANG LL, Lu HW, Li LL, Gao YH, et al
Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study.
Respir Res. 2023;24:84.
PubMed Abstract available

CHOI YJ, Han H, Lee JH, Lee J, et al
Particulate matter(10)-induced airway inflammation and fibrosis can be regulated by chitinase-1 suppression.
Respir Res. 2023;24:85.
PubMed Abstract available

TALAEI M, Emmett PM, Granell R, Tabatabaeian H, et al
Dietary patterns, lung function and asthma in childhood: a longitudinal study.
Respir Res. 2023;24:82.
PubMed Abstract available

HEIDARI-FOROOZAN M, Aryan A, Esfahani Z, Shahrbaf MA, et al
National, subnational and risk attributed burden of chronic respiratory diseases in Iran from 1990 to 2019.
Respir Res. 2023;24:74.
PubMed Abstract available

KANG J, Lee R, Lee SW
Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD.
Respir Res. 2023;24:75.
PubMed Abstract available

ZHANG Z, Wang J, Li Y, Liu F, et al
Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD.
Respir Res. 2023;24:73.
PubMed Abstract available

HORTON DB, Neikirk AL, Yang Y, Huang C, et al
Childhood asthma diagnoses declined during the COVID-19 pandemic in the United States.
Respir Res. 2023;24:72.
PubMed Abstract available

FAVERIO P, Ronco R, Monzio Compagnoni M, Franchi M, et al
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study.
Respir Res. 2023;24:70.
PubMed Abstract available

SONG Y, Fu W, Zhang Y, Huang D, et al
Azithromycin ameliorated cigarette smoke-induced airway epithelial barrier dysfunction by activating Nrf2/GCL/GSH signaling pathway.
Respir Res. 2023;24:69.
PubMed Abstract available

February 2023

WANG XW, Wang T, Schaub DP, Chen C, et al
Benchmarking omics-based prediction of asthma development in children.
Respir Res. 2023;24:63.
PubMed Abstract available

LIN X, Wang L, Lu X, Zhang Y, et al
Targeting of G-protein coupled receptor 40 alleviates airway hyperresponsiveness through RhoA/ROCK1 signaling pathway in obese asthmatic mice.
Respir Res. 2023;24:56.
PubMed Abstract available

KWOK WC, Tam TCC, Lam DCL, Leung JKC, et al
Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong.
Respir Res. 2023;24:53.
PubMed Abstract available

XU X, Zheng F, Xu S, Hu M, et al
Decreased ubiquitin modifying enzyme A20 associated with hyper-responsiveness to ovalbumin challenge following intrauterine growth restriction.
Respir Res. 2023;24:50.
PubMed Abstract available

KOKTURK N, Khodayari N, Lascano J, Riley EL, et al
Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function.
Respir Res. 2023;24:40.
PubMed Abstract available

HAYDEN LP, Hobbs BD, Busch R, Cho MH, et al
X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association study.
Respir Res. 2023;24:38.
PubMed Abstract available

January 2023

DUAN Y, Zhou S, Wang J
BRD4 is involved in viral exacerbation of chronic obstructive pulmonary disease.
Respir Res. 2023;24:37.
PubMed Abstract available

SAFONOVA E, Yawn BP, Welte T, Wang C, et al
Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
Respir Res. 2023;24:35.
PubMed Abstract available

MEISCHL T, Schmid-Scherzer K, Vafai-Tabrizi F, Wurzinger G, et al
The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry.
Respir Res. 2023;24:34.
PubMed Abstract available

TU X, Gomez HM, Kim RY, Brown AC, et al
Airway and parenchyma transcriptomics in a house dust mite model of experimental asthma.
Respir Res. 2023;24:32.
PubMed Abstract available

MELO-DIAS S, Cabral M, Furtado A, Souto-Miranda S, et al
Responsiveness to pulmonary rehabilitation in COPD is associated with changes in microbiota.
Respir Res. 2023;24:29.
PubMed Abstract available

BUSCHUR KL, Riley C, Saferali A, Castaldi P, et al
Distinct COPD subtypes in former smokers revealed by gene network perturbation analysis.
Respir Res. 2023;24:30.
PubMed Abstract available

GARCIA-GARCIA ML, Sastre B, Arroyas M, Beato M, et al
Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age.
Respir Res. 2023;24:26.
PubMed Abstract available

KRUK D, Yeung ACY, Faiz A, Ten Hacken NHT, et al
Gene expression profiles in mesenchymal stromal cells from bone marrow, adipose tissue and lung tissue of COPD patients and controls.
Respir Res. 2023;24:22.
PubMed Abstract available

VERSTRAETE K, Das N, Gyselinck I, Topalovic M, et al
Principal component analysis of flow-volume curves in COPDGene to link spirometry with phenotypes of COPD.
Respir Res. 2023;24:20.
PubMed Abstract available

SPRINGVLOET L, Triemstra M, Knottnerus B, Rolink M, et al
Validation of the CaReQoL asthma: a patient reported outcome measure for monitoring the perceived effects of pulmonary rehabilitation in adult patients with severe refractory asthma.
Respir Res. 2023;24:14.
PubMed Abstract available

GOULD GS, Hurst JR, Trofor A, Alison JA, et al
Recognising the importance of chronic lung disease: a consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group).
Respir Res. 2023;24:15.
PubMed Abstract available

QURAISHI E, Jibuaku C, Lisik D, Wennergren G, et al
Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden.
Respir Res. 2023;24:10.
PubMed Abstract available

ZHOU Z, Liang S, Zhou Z, Liu J, et al
TGF-beta1 promotes SCD1 expression via the PI3K-Akt-mTOR-SREBP1 signaling pathway in lung fibroblasts.
Respir Res. 2023;24:8.
PubMed Abstract available

BANDEIRA E, Jang SC, Lasser C, Johansson K, et al
Effects of mesenchymal stem cell-derived nanovesicles in experimental allergic airway inflammation.
Respir Res. 2023;24:3.
PubMed Abstract available

WORTH H, Buhl R, Criee CP, Kardos P, et al
In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations.
Respir Res. 2023;24:2.
PubMed Abstract available

December 2022

CHENG WH, Kao SY, Chen CL, Yuliani FS, et al
Amphiregulin induces CCN2 and fibronectin expression by TGF-beta through EGFR-dependent pathway in lung epithelial cells.
Respir Res. 2022;23:381.
PubMed Abstract available

LIU D, Xu W, Tang Y, Cao J, et al
Nebulization of risedronate alleviates airway obstruction and inflammation of chronic obstructive pulmonary diseases via suppressing prenylation-dependent RAS/ERK/NF-kappaB and RhoA/ROCK1/MLCP signaling.
Respir Res. 2022;23:380.
PubMed Abstract available

CAY P, Singer CA, Ba MA
Gene network analysis for identification of microRNA biomarkers for asthma.
Respir Res. 2022;23:378.
PubMed Abstract available

WANG R, Li W, Dai H, Zhu M, et al
Correction to: PKD1 deficiency induces Bronchiectasis in a porcine ADPKD model.
Respir Res. 2022;23:373.
PubMed

AMEGADZIE JE, Gamble JM, Farrell J, Gao Z, et al
Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled beta2-agonists in patients with asthma, COPD or asthma-COPD overlap.
Respir Res. 2022;23:364.
PubMed Abstract available

NOMURA N, Matsumoto H, Yokoyama A, Nishimura Y, et al
Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes.
Respir Res. 2022;23:365.
PubMed Abstract available

HUANG Q, Wang Y, Zhang L, Qian W, et al
Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD.
Respir Res. 2022;23:367.
PubMed Abstract available

TERRANOVA L, Rise P, Gramegna A, Pinna C, et al
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients.
Respir Res. 2022;23:363.
PubMed Abstract available

POURESLAMI I, FitzGerald JM, Tregobov N, Goldstein RS, et al
Health literacy in asthma and chronic obstructive pulmonary disease (COPD) care: a narrative review and future directions.
Respir Res. 2022;23:361.
PubMed Abstract available

DAI Z, Liu X, Zeng H, Chen Y, et al
Long noncoding RNA HOTAIR facilitates pulmonary vascular endothelial cell apoptosis via DNMT1 mediated hypermethylation of Bcl-2 promoter in COPD.
Respir Res. 2022;23:356.
PubMed Abstract available

GRIBBEN KC, Wyss AB, Poole JA, Farazi PA, et al
Correction to: CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study.
Respir Res. 2022;23:350.
PubMed

MIRAVITLLES M, Turner AM, Torres-Duran M, Tanash H, et al
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
Respir Res. 2022;23:352.
PubMed Abstract available

GOEL K, Egersdorf N, Gill A, Cao D, et al
Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension.
Respir Res. 2022;23:349.
PubMed Abstract available

MIRAVITLLES M, Garcia-Rivero JL, Ribera X, Galera J, et al
Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis.
Respir Res. 2022;23:347.
PubMed Abstract available

DUPONT A, Couffignal C, Arias C, Salah K, et al
Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients.
Respir Res. 2022;23:342.
PubMed Abstract available

STUBBS MA, Clark VL, Gibson PG, Yorke J, et al
Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma.
Respir Res. 2022;23:341.
PubMed Abstract available

ELLER MCN, Pierantozzi Vergani K, Saraiva-Romanholo BM, de Souza Xavier Costa N, et al
Bronchial eosinophils, neutrophils, and CD8 + T cells influence asthma control and lung function in schoolchildren and adolescents with severe treatment-resistant asthma.
Respir Res. 2022;23:335.
PubMed Abstract available

VAN ZELST CM, Goossens LMA, Witte JA, Braunstahl GJ, et al
Stratification of COPD patients towards personalized medicine: reproduction and formation of clusters.
Respir Res. 2022;23:336.
PubMed Abstract available

TERPSTRA LC, Altenburg J, Bronsveld I, de Kruif MD, et al
Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis.
Respir Res. 2022;23:330.
PubMed Abstract available

GAO YH, Lu HW, Mao B, Guan WJ, et al
The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational study.
Respir Res. 2022;23:328.
PubMed Abstract available

November 2022

LI W, Wang B, Tan M, Song X, et al
Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
Respir Res. 2022;23:321.
PubMed Abstract available

FEIZI H, Alizadeh M, Nejadghaderi SA, Noori M, et al
The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019.
Respir Res. 2022;23:319.
PubMed Abstract available

MA L, Zhu M, Li G, Gai J, et al
Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.
Respir Res. 2022;23:316.
PubMed Abstract available

WANG WW, Mao B, Liu Y, Gu SY, et al
Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.
Respir Res. 2022;23:317.
PubMed Abstract available

WILSON AC, Bon JM, Mason S, Diaz AA, et al
Increased chest CT derived bone and muscle measures capture markers of improved morbidity and mortality in COPD.
Respir Res. 2022;23:311.
PubMed Abstract available

TEJWANI V, Woo H, Liu C, Tillery AK, et al
Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS.
Respir Res. 2022;23:310.
PubMed Abstract available

LU J, Ge H, Qi L, Zhang S, et al
Subtyping preserved ratio impaired spirometry (PRISm) by using quantitative HRCT imaging characteristics.
Respir Res. 2022;23:309.
PubMed Abstract available

GRIBBEN KC, Wyss AB, Poole JA, Farazi PA, et al
CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study.
Respir Res. 2022;23:305.
PubMed Abstract available

October 2022

ZHAO N, Wu F, Peng J, Zheng Y, et al
Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity.
Respir Res. 2022;23:298.
PubMed Abstract available

WANG R, Li W, Dai H, Zhu M, et al
PKD1 deficiency induces Bronchiectasis in a porcine ADPKD model.
Respir Res. 2022;23:292.
PubMed Abstract available

XIA M, Xu F, Ni H, Wang Q, et al
Neutrophil activation and NETosis are the predominant drivers of airway inflammation in an OVA/CFA/LPS induced murine model.
Respir Res. 2022;23:289.
PubMed Abstract available

CHOI H, Kim SH, Han K, Park TS, et al
Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis.
Respir Res. 2022;23:288.
PubMed Abstract available

RAO X, Dong H, Zhang W, Sun H, et al
MiR-493-5p inhibits Th9 cell differentiation in allergic asthma by targeting FOXO1.
Respir Res. 2022;23:286.
PubMed Abstract available

JACOBS M, Verschraegen S, Salhi B, Anckaert J, et al
IL-10 producing regulatory B cells are decreased in blood from smokers and COPD patients.
Respir Res. 2022;23:287.
PubMed Abstract available

CASADEVALL C, Sancho-Munoz A, Vicente I, Pascual-Guardia S, et al
Influence of COPD systemic environment on the myogenic function of muscle precursor cells in vitro.
Respir Res. 2022;23:282.
PubMed Abstract available

ANDREAS A, Maloy A, Nyunoya T, Zhang Y, et al
The FoxP1 gene regulates lung function, production of matrix metalloproteinases and inflammatory mediators, and viability of lung epithelia.
Respir Res. 2022;23:281.
PubMed Abstract available

HUSSAIN SS, Edwards YJK, Libby EF, Stanford D, et al
Comparative transcriptomics in human COPD reveals dysregulated genes uniquely expressed in ferrets.
Respir Res. 2022;23:277.
PubMed Abstract available

YI F, Zhan C, Liu B, Li H, et al
Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
Respir Res. 2022;23:279.
PubMed Abstract available

JIANG T, Hu W, Zhang S, Ren C, et al
Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis.
Respir Res. 2022;23:269.
PubMed Abstract available

PAULIN LM, Halenar MJ, Edwards KC, Lauten K, et al
Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study.
Respir Res. 2022;23:273.
PubMed Abstract available

September 2022

FALLAHZADEH A, Sharifnejad Tehrani Y, Sheikhy A, Ghamari SH, et al
The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019.
Respir Res. 2022;23:268.
PubMed Abstract available

DIVO MJ, Marin JM, Casanova C, Cabrera Lopez C, et al
Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease.
Respir Res. 2022;23:267.
PubMed Abstract available

XU J, Sun X, Zhu H, Cao Y, et al
Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma.
Respir Res. 2022;23:262.
PubMed Abstract available

DALEY-YATES P, Keppler B, Baines A, Bardsley G, et al
Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
Respir Res. 2022;23:258.
PubMed Abstract available

PEI Y, Wei Y, Peng B, Wang M, et al
Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD.
Respir Res. 2022;23:260.
PubMed Abstract available

MAGWENZI P, Rusakaniko S, Sibanda EN, Gumbo FZ, et al
Challenges in the diagnosis of asthma in children, what are the solutions? A scoping review of 3 countries in sub Saharan Africa.
Respir Res. 2022;23:254.
PubMed Abstract available

YAMADA H, Matsumoto I, Makita N, Arita Y, et al
Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study.
Respir Res. 2022;23:255.
PubMed Abstract available

LIU Y, Shi G
Roles of sirtuins in asthma.
Respir Res. 2022;23:251.
PubMed Abstract available

HUANG D, He D, Gong L, Yao R, et al
A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease.
Respir Res. 2022;23:250.
PubMed Abstract available

GRIBBEN KC, Poole JA, Nelson AJ, Farazi PA, et al
Relationships of serum CC16 levels with smoking status and lung function in COPD.
Respir Res. 2022;23:247.
PubMed Abstract available

LEUNG C, Ryu MH, Bolling AK, Maestre-Batlle D, et al
Peroxisome proliferator-activated receptor gamma gene variants modify human airway and systemic responses to indoor dibutyl phthalate exposure.
Respir Res. 2022;23:248.
PubMed Abstract available

FENG KN, Meng P, Zou XL, Zhang M, et al
IL-37 protects against airway remodeling by reversing bronchial epithelial-mesenchymal transition via IL-24 signaling pathway in chronic asthma.
Respir Res. 2022;23:244.
PubMed Abstract available

ZHOU J, Yi F, Wu F, Xu P, et al
Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China.
Respir Res. 2022;23:243.
PubMed Abstract available

LENG S, Picchi MA, Meek PM, Jiang M, et al
Wood smoke exposure affects lung aging, quality of life, and all-cause mortality in New Mexican smokers.
Respir Res. 2022;23:236.
PubMed Abstract available

LEE HW, Baek MG, Choi S, Ahn YH, et al
Peripheral blood transcriptomic clusters uncovered immune phenotypes of asthma.
Respir Res. 2022;23:237.
PubMed Abstract available

KHODAYARI N, Oshins R, Mehrad B, Lascano JE, et al
Cigarette smoke exposed airway epithelial cell-derived EVs promote pro-inflammatory macrophage activation in alpha-1 antitrypsin deficiency.
Respir Res. 2022;23:232.
PubMed Abstract available

LEE CH, Kim MS, Yeo SH, Rhee CK, et al
Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
Respir Res. 2022;23:231.
PubMed Abstract available

ALTHOFF MD, Jimenez G, Peterson R, Jin Y, et al
Differences in L-arginine metabolism and asthma morbidity among asthma patients with and without obstructive sleep apnea.
Respir Res. 2022;23:230.
PubMed Abstract available

DAI C, Wu F, Wang Z, Peng J, et al
The association between small airway dysfunction and aging: a cross-sectional analysis from the ECOPD cohort.
Respir Res. 2022;23:229.
PubMed Abstract available

August 2022

SU X, Wu W, Zhu Z, Lin X, et al
The effects of epithelial-mesenchymal transitions in COPD induced by cigarette smoke: an update.
Respir Res. 2022;23:225.
PubMed Abstract available

SHIN S, Kong S, Kang D, Lee G, et al
Longitudinal changes in pulmonary function and patient-reported outcomes after lung cancer surgery.
Respir Res. 2022;23:224.
PubMed Abstract available

ROGLIANI P, Cavalli F, Ritondo BL, Cazzola M, et al
Sex differences in adult asthma and COPD therapy: a systematic review.
Respir Res. 2022;23:222.
PubMed Abstract available

KOMURA M, Sato T, Yoshikawa H, Nitta NA, et al
Propylene glycol, a component of electronic cigarette liquid, damages epithelial cells in human small airways.
Respir Res. 2022;23:216.
PubMed Abstract available

HURST JR, Han MK, Singh B, Sharma S, et al
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.
Respir Res. 2022;23:213.
PubMed Abstract available

JO YS, Kim KJ, Rhee CK, Yoo KH, et al
Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease.
Respir Res. 2022;23:212.
PubMed Abstract available

SMALLWOOD N, Pascoe A, Vogrin S, Philip J, et al
SINFONIA study protocol: a phase II/III randomised controlled trial examining benefits of guided online group singing in people with chronic obstructive pulmonary disease and interstitial lung disease and their carers.
Respir Res. 2022;23:208.
PubMed Abstract available

DE LUCA G, Nardin M, Algowhary M, Uguz B, et al
Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry.
Respir Res. 2022;23:207.
PubMed Abstract available

DI STEFANO A, Dossena F, Gnemmi I, D'Anna SE, et al
Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease.
Respir Res. 2022;23:200.
PubMed Abstract available

July 2022

BODUM KS, Hjerrild BE, Dalsgaard S, Rubak SLM, et al
Behavioural side effects of inhaled corticosteroids among children and adolescents with asthma.
Respir Res. 2022;23:192.
PubMed Abstract available

KAN M, Sun M, Jiang X, Diwadkar AR, et al
CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids.
Respir Res. 2022;23:193.
PubMed Abstract available

RIEG AD, Suleiman S, Anker C, Bunting NA, et al
Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation.
Respir Res. 2022;23:189.
PubMed Abstract available

CHEN CH, Wu CD, Lee YL, Lee KY, et al
Air pollution enhance the progression of restrictive lung function impairment and diffusion capacity reduction: an elderly cohort study.
Respir Res. 2022;23:186.
PubMed Abstract available

BIGNOLD R, Shammout B, Rowley JE, Repici M, et al
Chemokine CXCL12 drives pericyte accumulation and airway remodeling in allergic airway disease.
Respir Res. 2022;23:183.
PubMed Abstract available

LEEM AY, Kim YS, Chung KS, Park MS, et al
Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity.
Respir Res. 2022;23:185.
PubMed Abstract available

HOU J, Wang X, Su C, Ma W, et al
Reduced frequencies of Foxp3(+)GARP(+) regulatory T cells in COPD patients are associated with multi-organ loss of tissue phenotype.
Respir Res. 2022;23:176.
PubMed Abstract available

June 2022

GOUDARZI H, Kimura H, Kimura H, Makita H, et al
Effects of obesity on CC16 and their potential role in overweight/obese asthma.
Respir Res. 2022;23:174.
PubMed Abstract available

SURAYA R, Nagano T, Ryanto GRT, Effendi WI, et al
Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFkappaB inactivation.
Respir Res. 2022;23:173.
PubMed Abstract available

HONG Y, Deng M, Hu W, Zhang R, et al
Weak cough is associated with increased mortality in COPD patients with scheduled extubation: a two-year follow-up study.
Respir Res. 2022;23:166.
PubMed Abstract available

LE NPK, do Nascimento AF, Schneberger D, Quach CC, et al
Deficiency of leukocyte-specific protein 1 (LSP1) alleviates asthmatic inflammation in a mouse model.
Respir Res. 2022;23:165.
PubMed Abstract available

MARIN-OTO M, Sanz-Rubio D, Santamaria-Martos F, Benitez I, et al
Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea.
Respir Res. 2022;23:163.
PubMed Abstract available

QIN W, Huang H, Dai Y, Han W, et al
Proteome analysis of urinary biomarkers in a cigarette smoke-induced COPD rat model.
Respir Res. 2022;23:156.
PubMed Abstract available

LIU P, Wang Y, Zhang N, Zhao X, et al
Comprehensive identification of RNA transcripts and construction of RNA network in chronic obstructive pulmonary disease.
Respir Res. 2022;23:154.
PubMed Abstract available

LOPEZ-CAMPOS JL, Osaba L, Czischke K, Jardim JR, et al
Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis.
Respir Res. 2022;23:152.
PubMed Abstract available

SALO PM, Mendy A, Wilkerson J, Molsberry SA, et al
Serum antioxidant vitamins and respiratory morbidity and mortality: a pooled analysis.
Respir Res. 2022;23:150.
PubMed Abstract available

SCHNEIDER S, Merfort I, Idzko M, Zech A, et al
Blocking P2X purinoceptor 4 signalling alleviates cigarette smoke induced pulmonary inflammation.
Respir Res. 2022;23:148.
PubMed Abstract available

KIM SY, Lee HJ, Lee JK, Park TY, et al
Association between oxygen saturation level during bronchoscopy and post-bronchoscopy adverse events: a retrospective cohort study.
Respir Res. 2022;23:144.
PubMed Abstract available

May 2022

LEE H, Kovacs C, Mattman A, Hollander Z, et al
The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD.
Respir Res. 2022;23:141.
PubMed Abstract available

XIONG XF, Zhu M, Wu HX, Fan LL, et al
Immunophenotype in acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
Respir Res. 2022;23:137.
PubMed Abstract available

ALQARNI AA, Brand OJ, Pasini A, Alahmari M, et al
Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation.
Respir Res. 2022;23:136.
PubMed Abstract available

IHRIE MD, McQuade VL, Womble JT, Hegde A, et al
Exogenous leptin enhances markers of airway fibrosis in a mouse model of chronic allergic airways disease.
Respir Res. 2022;23:131.
PubMed Abstract available

PINCIKOVA T, Parrot T, Hjelte L, Hogman M, et al
MAIT cell counts are associated with the risk of hospitalization in COPD.
Respir Res. 2022;23:127.
PubMed Abstract available

JACKSON D, Walum J, Banerjee P, Lewis BW, et al
Th1 cytokines synergize to change gene expression and promote corticosteroid insensitivity in pediatric airway smooth muscle.
Respir Res. 2022;23:126.
PubMed Abstract available

ZHAN Y, Chen J, Wu J, Gu Y, et al
Human epididymis protein 4 aggravates airway inflammation and remodeling in chronic obstructive pulmonary disease.
Respir Res. 2022;23:120.
PubMed Abstract available

HUANG K, Li F, Wang X, Yan B, et al
Clinical and cytokine patterns of uncontrolled asthma with and without comorbid chronic rhinosinusitis: a cross-sectional study.
Respir Res. 2022;23:119.
PubMed Abstract available

LIU Y, Qu HQ, Qu J, Chang X, et al
Burden of rare coding variants reveals genetic heterogeneity between obese and non-obese asthma patients in the African American population.
Respir Res. 2022;23:116.
PubMed Abstract available

FENG J, Sun L, Sun X, Xu L, et al
Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013-2017: a nationwide population-based cohort study.
Respir Res. 2022;23:111.
PubMed Abstract available

GALGANI I, Annaratone M, Casula D, Di Maro G, et al
Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.
Respir Res. 2022;23:114.
PubMed Abstract available

KIM HS, An CH, Teller D, Moon SJ, et al
The role of retinoid-related orphan receptor-alpha in cigarette smoke-induced autophagic response.
Respir Res. 2022;23:110.
PubMed Abstract available

MAGNUSSON JM, Ericson P, Tengvall S, Stockfelt M, et al
Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
Respir Res. 2022;23:108.
PubMed Abstract available

VOGELMEIER CF, Worth H, Buhl R, Criee CP, et al
Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study.
Respir Res. 2022;23:109.
PubMed Abstract available

April 2022

YANG T, Cai B, Cao B, Kang J, et al
Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study.
Respir Res. 2022;23:106.
PubMed Abstract available

HAWTHORNE G, Richardson M, Greening NJ, Esliger D, et al
A proof of concept for continuous, non-invasive, free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD: a prospective cohort study.
Respir Res. 2022;23:102.
PubMed Abstract available

GHOSH AJ, Hobbs BD, Yun JH, Saferali A, et al
Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Respir Res. 2022;23:97.
PubMed Abstract available

GUIOT J, Henket M, Frix AN, Gester F, et al
Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
Respir Res. 2022;23:89.
PubMed Abstract available

ZOU J, Sun T, Song X, Liu YM, et al
Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data.
Respir Res. 2022;23:90.
PubMed Abstract available

LI R, Chen Y, Zhao A, Huang L, et al
Exploring genetic association of insomnia with allergic disease and asthma: a bidirectional Mendelian randomization study.
Respir Res. 2022;23:84.
PubMed Abstract available

GOMEZ N, James V, Onion D, Fairclough LC, et al
Extracellular vesicles and chronic obstructive pulmonary disease (COPD): a systematic review.
Respir Res. 2022;23:82.
PubMed Abstract available

KELLY TL, Ward M, Pratt NL, Ramsay E, et al
The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians.
Respir Res. 2022;23:80.
PubMed Abstract available

March 2022

LEE KY, Wu SM, Kou HY, Chen KY, et al
Association of air pollution exposure with exercise-induced oxygen desaturation in COPD.
Respir Res. 2022;23:77.
PubMed Abstract available

YU C, Huang W, Zhou Z, Liang S, et al
Short isoform thymic stromal lymphopoietin reduces inflammation and aerobic glycolysis of asthmatic airway epithelium by antagonizing long isoform thymic stromal lymphopoietin.
Respir Res. 2022;23:75.
PubMed Abstract available

LU W, Tian Q, Xu R, Zhong C, et al
Short-term exposure to ambient air pollution and pneumonia hospital admission among patients with COPD: a time-stratified case-crossover study.
Respir Res. 2022;23:71.
PubMed Abstract available

YU H, Lin Y, Zhong Y, Guo X, et al
Impaired AT2 to AT1 cell transition in PM2.5-induced mouse model of chronic obstructive pulmonary disease.
Respir Res. 2022;23:70.
PubMed Abstract available

ROHL A, Baek SH, Kachroo P, Morrow JD, et al
Protein interaction networks provide insight into fetal origins of chronic obstructive pulmonary disease.
Respir Res. 2022;23:69.
PubMed Abstract available

ZHANG XY, Li W, Zhang JR, Li CY, et al
Roles of sirtuin family members in chronic obstructive pulmonary disease.
Respir Res. 2022;23:66.
PubMed Abstract available

HOFFMANN C, Maglakelidze M, von Schneidemesser E, Witt C, et al
Asthma and COPD exacerbation in relation to outdoor air pollution in the metropolitan area of Berlin, Germany.
Respir Res. 2022;23:64.
PubMed Abstract available

HSU CW, Suk CW, Hsu YP, Chang JH, et al
Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD.
Respir Res. 2022;23:63.
PubMed Abstract available

BRENNAN M, McDonnell MJ, Harrison MJ, Duignan N, et al
Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines.
Respir Res. 2022;23:58.
PubMed Abstract available

SHIN SH, Kwon SO, Kim V, Silverman EK, et al
Association of body mass index and COPD exacerbation among patients with chronic bronchitis.
Respir Res. 2022;23:52.
PubMed Abstract available

HUANG JJ, Yang XQ, Zhuo ZQ, Yuan L, et al
Clinical characteristics of plastic bronchitis in children: a retrospective analysis of 43 cases.
Respir Res. 2022;23:51.
PubMed Abstract available

WEITOFT M, Kadefors M, Stenberg H, Tufvesson E, et al
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics.
Respir Res. 2022;23:50.
PubMed Abstract available

MIRAVITLLES M, Soler-Cataluna JJ, Soriano JB, Garcia-Rio F, et al
Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study.
Respir Res. 2022;23:49.
PubMed Abstract available

KORN S, Howarth P, Smith SG, Price RG, et al
Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma.
Respir Res. 2022;23:45.
PubMed Abstract available

BLASKOVIC S, Donati Y, Ruchonnet-Metrailler I, Avila Y, et al
Early life exposure to nicotine modifies lung gene response after elastase-induced emphysema.
Respir Res. 2022;23:44.
PubMed Abstract available

DE VRIES M, Nwozor KO, Muizer K, Wisman M, et al
The relation between age and airway epithelial barrier function.
Respir Res. 2022;23:43.
PubMed Abstract available

IRIE H, Ozaki M, Chubachi S, Hegab AE, et al
Short-term intermittent cigarette smoke exposure enhances alveolar type 2 cell stemness via fatty acid oxidation.
Respir Res. 2022;23:41.
PubMed Abstract available

February 2022

CHEN Y, Kong D, Fu J, Zhang Y, et al
Associations between ambient temperature and adult asthma hospitalizations in Beijing, China: a time-stratified case-crossover study.
Respir Res. 2022;23:38.
PubMed Abstract available

MENZELLA F, Bargagli E, Aliani M, Bracciale P, et al
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
Respir Res. 2022;23:36.
PubMed Abstract available

KULBACKA-ORTIZ K, Triest FJJ, Franssen FME, Wouters EFM, et al
Restricted spirometry and cardiometabolic comorbidities: results from the international population based BOLD study.
Respir Res. 2022;23:34.
PubMed Abstract available

SCHAUNAMAN N, Dimasuay KG, Kraft M, Chu HW, et al
Tollip interaction with STAT3: a novel mechanism to regulate human airway epithelial responses to type 2 cytokines.
Respir Res. 2022;23:31.
PubMed Abstract available

MARQUES A, Souto-Miranda S, Machado A, Oliveira A, et al
COPD profiles and treatable traits using minimal resources: identification, decision tree and stability over time.
Respir Res. 2022;23:30.
PubMed Abstract available

PARK SW, Lim MN, Kim WJ, Bak SH, et al
Quantitative assessment the longitudinal changes of pulmonary vascular counts in chronic obstructive pulmonary disease.
Respir Res. 2022;23:29.
PubMed Abstract available

CUI Y, Zhan Z, Ma Y, Huang K, et al
Clinical and economic burden of comorbid coronary artery disease in patients with acute exacerbation of chronic obstructive pulmonary disease: sex differences in a nationwide cohort study.
Respir Res. 2022;23:28.
PubMed Abstract available

WANG H, Zhong Y, Li N, Yu M, et al
Transcriptomic analysis and validation reveal the pathogenesis and a novel biomarker of acute exacerbation of chronic obstructive pulmonary disease.
Respir Res. 2022;23:27.
PubMed Abstract available

SINGH D, Wild JM, Saralaya D, Lawson R, et al
Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial.
Respir Res. 2022;23:26.
PubMed Abstract available

January 2022

WU W, Gao J, Chen D, Chen G, et al
Epithelial microRNA-30a-3p targets RUNX2/HMGB1 axis to suppress airway eosinophilic inflammation in asthma.
Respir Res. 2022;23:17.
PubMed Abstract available

MELO-DIAS S, Valente C, Andrade L, Marques A, et al
Saliva as a non-invasive specimen for COPD assessment.
Respir Res. 2022;23:16.
PubMed Abstract available

KOO HK, Hoth KF, Make BJ, Regan EA, et al
Optimism is associated with respiratory symptoms and functional status in chronic obstructive pulmonary disease.
Respir Res. 2022;23:19.
PubMed Abstract available

KLONT F, Horvatovich P, Bowler RP, van Rikxoort E, et al
Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans.
Respir Res. 2022;23:15.
PubMed Abstract available

LUTHGEN M, Ruller S, Herzmann C
Characteristics of the deventilation syndrome in COPD patients treated with non-invasive ventilation: an explorative study.
Respir Res. 2022;23:13.
PubMed Abstract available

HUANG X, Guan W, Xiang B, Wang W, et al
MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model.
Respir Res. 2022;23:11.
PubMed Abstract available

CHIU YC, Lee SW, Liu CW, Lan TY, et al
Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.
Respir Res. 2022;23:10.
PubMed Abstract available

HO T, Nichols M, Nair G, Radford K, et al
Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease.
Respir Res. 2022;23:8.
PubMed Abstract available

ZHU Z, Lian X, Su X, Wu W, et al
Exosomes derived from adipose-derived stem cells alleviate cigarette smoke-induced lung inflammation and injury by inhibiting alveolar macrophages pyroptosis.
Respir Res. 2022;23:5.
PubMed Abstract available

LOMMATZSCH M, Speer T, Herr C, Jorres RA, et al
IgE is associated with exacerbations and lung function decline in COPD.
Respir Res. 2022;23:1.
PubMed Abstract available

December 2021

TIAN F, Song W, Wang L, Zeng Q, et al
NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study.
Respir Res. 2021;22:321.
PubMed Abstract available

MCKENZIE J, Nisha P, Cannon-Bailey S, Cain C, et al
Overnight variation in tidal expiratory flow limitation in COPD patients and its correction: an observational study.
Respir Res. 2021;22:319.
PubMed Abstract available

HERNANDEZ CORDERO AI, Yang CX, Li X, Milne S, et al
Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease.
Respir Res. 2021;22:316.
PubMed Abstract available

SKIBBA ME, Xu X, Weiss K, Huisken J, et al
Role of Secretoglobin(+) (club cell) NFkappaB/RelA-TGFbeta signaling in aero-allergen-induced epithelial plasticity and subepithelial myofibroblast transdifferentiation.
Respir Res. 2021;22:315.
PubMed Abstract available

MASPERO J, Agache IO, Kamei T, Yoshida M, et al
Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial.
Respir Res. 2021;22:311.
PubMed Abstract available

BURBANK AJ, Schworer SA, Sood A, Almond M, et al
Airway IL-1beta associates with IL-5 production following dust mite allergen inhalation in humans.
Respir Res. 2021;22:309.
PubMed Abstract available

November 2021

KOSHY K, Sha J, Bennetts K, Langton D, et al
Safety of delivering bronchial thermoplasty in two treatment sessions.
Respir Res. 2021;22:307.
PubMed Abstract available

CUI Y, Zhang W, Ma Y, Zhan Z, et al
Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.
Respir Res. 2021;22:301.
PubMed Abstract available

JOO DH, Lee KH, Lee CH, Woo J, et al
Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease.
Respir Res. 2021;22:297.
PubMed Abstract available

SCHMIDT J, Martin A, Wenzel C, Weber J, et al
Control of the expiratory flow in a lung model and in healthy volunteers with an adjustable flow regulator: a combined bench and randomized crossover study.
Respir Res. 2021;22:292.
PubMed Abstract available

SVERRILD A, Leadbetter J, Porsbjerg C
The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations.
Respir Res. 2021;22:287.
PubMed Abstract available

SU X, Chen J, Lin X, Chen X, et al
FERMT3 mediates cigarette smoke-induced epithelial-mesenchymal transition through Wnt/beta-catenin signaling.
Respir Res. 2021;22:286.
PubMed Abstract available

October 2021

VOGELMEIER CF, Jones PW, Kerwin EM, Boucot IH, et al
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.
Respir Res. 2021;22:279.
PubMed Abstract available

HARDING JN, Gross M, Patel V, Potter S, et al
Association between particulate matter containing EPFRs and neutrophilic asthma through AhR and Th17.
Respir Res. 2021;22:275.
PubMed Abstract available

YOSHIZAKI A, Nagano T, Izumi S, Nishiuma T, et al
Characteristics of the nocturnal desaturation waveform pattern of SpO2 in COPD patients: an observational study.
Respir Res. 2021;22:276.
PubMed Abstract available

NG J, Pacheco-Rodriguez G, Begley L, Huang YJ, et al
The lung microbiome in end-stage Lymphangioleiomyomatosis.
Respir Res. 2021;22:277.
PubMed Abstract available

LI N, Dai Z, Wang Z, Deng Z, et al
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.
Respir Res. 2021;22:274.
PubMed Abstract available

CHAPMAN KR, Wise RA, Scirica BM, Bhatt DL, et al
Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers.
Respir Res. 2021;22:272.
PubMed Abstract available

SHIRAISHI M, Higashimoto Y, Sugiya R, Mizusawa H, et al
Diaphragmatic excursion is correlated with the improvement in exercise tolerance after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.
Respir Res. 2021;22:271.
PubMed Abstract available

TUPPER OD, Ulrik CS
Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma.
Respir Res. 2021;22:269.
PubMed Abstract available

QIU M, Jiang J, Nian X, Wang Y, et al
Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Respir Res. 2021;22:264.
PubMed Abstract available

CARSTENSEN S, Gress C, Erpenbeck VJ, Kazani SD, et al
Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor.
Respir Res. 2021;22:262.
PubMed Abstract available

USMANI O, Roche N, Wahab E, Israel S, et al
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res. 2021;22:261.
PubMed Abstract available

CARL J, Schultz K, Janssens T, von Leupoldt A, et al
The "can do, do do" concept in individuals with chronic obstructive pulmonary disease: an exploration of psychological mechanisms.
Respir Res. 2021;22:260.
PubMed Abstract available

August 2021

HUBER MB, Schneider N, Kirsch F, Schwarzkopf L, et al
Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life.
Respir Res. 2021;22:226.
PubMed Abstract available

VOGT S, Leuppi JD, Schuetz P, Mueller B, et al
Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial.
Respir Res. 2021;22:227.
PubMed Abstract available

HSU HT, Wu CD, Chung MC, Shen TC, et al
The effects of traffic-related air pollutants on chronic obstructive pulmonary disease in the community-based general population.
Respir Res. 2021;22:217.
PubMed Abstract available

July 2021

LONG H, Xu H, Janssens JP, Guo Y, et al
Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials.
Respir Res. 2021;22:209.
PubMed Abstract available

PU X, Liu L, Feng B, Zhang Z, et al
Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis.
Respir Res. 2021;22:201.
PubMed Abstract available

HARBAUM L, Hennigs JK, Simon M, Oqueka T, et al
Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study.
Respir Res. 2021;22:199.
PubMed Abstract available

VAN DEN BERGE M, De Backer J, Van Holsbeke C, De Backer W, et al
Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids.
Respir Res. 2021;22:191.
PubMed Abstract available

ZHU J, Wang F, Feng X, Li B, et al
Family with sequence similarity 13 member A mediates TGF-beta1-induced EMT in small airway epithelium of patients with chronic obstructive pulmonary disease.
Respir Res. 2021;22:192.
PubMed Abstract available

June 2021

MURO S, Sugiura H, Darken P, Dorinsky P, et al
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts.
Respir Res. 2021;22:187.
PubMed Abstract available

KOARAI A, Yamada M, Ichikawa T, Fujino N, et al
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis.
Respir Res. 2021;22:183.
PubMed Abstract available

MURO S, Suzuki M, Nakamura S, Wang JR, et al
Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysis.
Respir Res. 2021;22:180.
PubMed Abstract available

GU Y, Ye X, Liu Y, Wang Y, et al
A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease.
Respir Res. 2021;22:176.
PubMed Abstract available

ANDELID K, Ost K, Andersson A, Mohamed E, et al
Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis.
Respir Res. 2021;22:172.
PubMed Abstract available

May 2021

SIVAPALAN P, Rutishauser J, Ulrik CS, Leuppi JD, et al
Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
Respir Res. 2021;22:155.
PubMed Abstract available

ZHENG ZG, Sun WZ, Hu JY, Jie ZJ, et al
Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial.
Respir Res. 2021;22:149.
PubMed Abstract available

JACOBSEN PA, van 't Hul AJ, Djamin RS, Antons JC, et al
Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment.
Respir Res. 2021;22:147.
PubMed Abstract available

WEISS DJ, Segal K, Casaburi R, Hayes J, et al
Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.
Respir Res. 2021;22:142.
PubMed Abstract available

GLOECKL R, Schneeberger T, Leitl D, Reinold T, et al
Whole-body vibration training versus conventional balance training in patients with severe COPD-a randomized, controlled trial.
Respir Res. 2021;22:138.
PubMed Abstract available

April 2021

HEALY C, Munoz-Wolf N, Strydom J, Faherty L, et al
Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.
Respir Res. 2021;22:133.
PubMed Abstract available

SINGH D, Criner GJ, Dransfield MT, Halpin DMG, et al
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
Respir Res. 2021;22:130.
PubMed Abstract available

PRATTE KA, Curtis JL, Kechris K, Couper D, et al
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
Respir Res. 2021;22:127.
PubMed Abstract available

MAJORSKI DS, Magnet FS, Thilemann S, Schmoor C, et al
Portable NIV for patients with moderate to severe COPD: two randomized crossover trials.
Respir Res. 2021;22:123.
PubMed Abstract available

ZHANG WZ, Hoffman KL, Schiffer KT, Oromendia C, et al
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
Respir Res. 2021;22:126.
PubMed Abstract available

SINGH R, Belchamber KBR, Fenwick PS, Chana K, et al
Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD.
Respir Res. 2021;22:113.
PubMed Abstract available

KIM V, Dolliver WR, Nath HP, Grumley SA, et al
Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease.
Respir Res. 2021;22:110.
PubMed

LI X, Noell G, Tabib T, Gregory AD, et al
Single cell RNA sequencing identifies IGFBP5 and QKI as ciliated epithelial cell genes associated with severe COPD.
Respir Res. 2021;22:100.
PubMed Abstract available

March 2021

CHUBACHI S, Yamada Y, Yamada M, Yokoyama Y, et al
Differences in airway lumen area between supine and upright computed tomography in patients with chronic obstructive pulmonary disease.
Respir Res. 2021;22:95.
PubMed Abstract available

MACHADO FVC, Spruit MA, Groenen MTJ, Houben-Wilke S, et al
Frequency and functional translation of low muscle mass in overweight and obese patients with COPD.
Respir Res. 2021;22:93.
PubMed Abstract available

PAN K, Lu J, Song Y
Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-gamma/TGF-beta1/Smad2/3 signalling pathway.
Respir Res. 2021;22:91.
PubMed Abstract available

ZHENG J, Baldi S, Zhao L, Li H, et al
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.
Respir Res. 2021;22:90.
PubMed Abstract available

PARK HJ, Kim SR, Kim S, Lee HS, et al
Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease.
Respir Res. 2021;22:87.
PubMed Abstract available

SERRE J, Tanjeko AT, Mathyssen C, Vanherwegen AS, et al
Enhanced lung inflammatory response in whole-body compared to nose-only cigarette smoke-exposed mice.
Respir Res. 2021;22:86.
PubMed Abstract available

BLERVAQUE L, Prefaut C, Forthin H, Maffre F, et al
Efficacy of a long-term pulmonary rehabilitation maintenance program for COPD patients in a real-life setting: a 5-year cohort study.
Respir Res. 2021;22:79.
PubMed Abstract available

CAO Y, Xing Z, Long H, Huang Y, et al
Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit.
Respir Res. 2021;22:77.
PubMed Abstract available

February 2021

PEROTIN JM, Polette M, Deslee G, Dormoy V, et al
CiliOPD: a ciliopathy-associated COPD endotype.
Respir Res. 2021;22:74.
PubMed Abstract available

LI LY, Yan TS, Yang J, Li YQ, et al
Impulse oscillometry for detection of small airway dysfunction in subjects with chronic respiratory symptoms and preserved pulmonary function.
Respir Res. 2021;22:68.
PubMed Abstract available

MALVISI L, Taddei L, Yarraguntla A, Wilkinson TMA, et al
Sputum sample positivity for Haemophilus influenzae or Moraxella catarrhalis in acute exacerbations of chronic obstructive pulmonary disease: evaluation of association with positivity at earlier stable disease timepoints.
Respir Res. 2021;22:67.
PubMed Abstract available

GULEA C, Zakeri R, Alderman V, Morgan A, et al
Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.
Respir Res. 2021;22:64.
PubMed Abstract available

YANG N, Singhera GK, Yan YX, Pieper MP, et al
Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells.
Respir Res. 2021;22:65.
PubMed Abstract available

PISON C, Shah PL, Slebos DJ, Ninane V, et al
Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes.
Respir Res. 2021;22:62.
PubMed Abstract available

SAITO T, Ichikawa T, Numakura T, Yamada M, et al
PGC-1alpha regulates airway epithelial barrier dysfunction induced by house dust mite.
Respir Res. 2021;22:63.
PubMed Abstract available

CHEN W, Sadatsafavi M, FitzGerald JM, Lynd LD, et al
Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis.
Respir Res. 2021;22:59.
PubMed Abstract available

CORDOBA-LANUS E, Cazorla-Rivero S, Garcia-Bello MA, Mayato D, et al
Telomere length dynamics over 10-years and related outcomes in patients with COPD.
Respir Res. 2021;22:56.
PubMed Abstract available

SAVRAN O, Godtfredsen N, Sorensen T, Jensen C, et al
COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
Respir Res. 2021;22:54.
PubMed Abstract available

KANG J, Lee JS, Lee SW, Lee JB, et al
Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials.
Respir Res. 2021;22:55.
PubMed Abstract available

VAN DEN BERG MPM, Nijboer-Brinksma S, Bos IST, van den Berge M, et al
The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
Respir Res. 2021;22:48.
PubMed Abstract available

WANG Y, Liao K, Liu B, Niu C, et al
GITRL on dendritic cells aggravates house dust mite-induced airway inflammation and airway hyperresponsiveness by modulating CD4(+) T cell differentiation.
Respir Res. 2021;22:46.
PubMed Abstract available

KIM J, Kim B, Bak SH, Oh YM, et al
A comparative study of chest CT findings regarding the effects of regional dust exposure on patients with COPD living in urban areas and rural areas near cement plants.
Respir Res. 2021;22:43.
PubMed Abstract available

SONG Q, Chen P, Liu XM
The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD.
Respir Res. 2021;22:39.
PubMed Abstract available

CALLE RUBIO M, Rodriguez Hermosa JL, de Torres JP, Marin JM, et al
COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort.
Respir Res. 2021;22:36.
PubMed Abstract available

GALDI F, Pedone C, McGee CA, George M, et al
Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study.
Respir Res. 2021;22:30.
PubMed Abstract available

January 2021

LEMAIRE F, Audonnet S, Perotin JM, Gaudry P, et al
The elastin peptide VGVAPG increases CD4(+) T-cell IL-4 production in patients with chronic obstructive pulmonary disease.
Respir Res. 2021;22:14.
PubMed Abstract available

BAGGE K, Sivapalan P, Eklof J, Hertz FB, et al
Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid-data from 43,636 outpatients.
Respir Res. 2021;22:11.
PubMed Abstract available

MAO X, Liang C, Niu H, Dong F, et al
Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry.
Respir Res. 2021;22:7.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.